For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Kid’s Eczema Study (38 Months)
Study Summary
Who Can Participate?
Children aged 2 to less than 12 with moderate to severe eczema may participate.
Inclusion Criteria
- have had a diagnosis of eczema for at least 6 months
- have 10% or more of their body surface area affect by eczema*
- have had inadequate response to 2 or more course of oral corticosteroid therapy give for 14 or more days in the past 6 months
* 1% of your child’s body surface area is roughly equal to the palm of your child’s hand (no wrist or fingers).
Additional Information
- No cost to participate or receive treatment
- Regular study visits with study doctors who specialize in treating eczema (22 visits)
- Will receive either an investigative oral treatment daily (study drug) or an injection every 2 or 4 weeks
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Up to 52 Weeks or 164 weeks depending on the treatment assigned to your child
For more information about this trial, please visit ClinicalTrials.gov
